Menu Expand
Diagnosis and Management of Adult Congenital Heart Disease E-Book

Diagnosis and Management of Adult Congenital Heart Disease E-Book

Michael A. Gatzoulis | Gary D. Webb | Piers E. F. Daubeney

(2017)

Additional Information

Book Details

Abstract

Designed to meet the needs of clinicians working with adults with congenital heart disease, Diagnosis and Management of Adult Congenital Heart Disease , by Drs. Michael A. Gatzoulis, Gary D. Webb, and Piers E. F. Daubeney, offers essential guidance on the anatomical issues, clinical presentation, diagnosis, and treatment options available to practitioners today. This latest edition features completely updated content, including new information for nurses and nurse practitioners who, now more than ever, are playing an important role in the care of adults with CHD. You'll also access four new chapters, illustrated congenital defects, coverage of long-term outcomes, and much more.

  • Drs. Gatzoulis, Webb, and Daubeney lead a team of experts ideally positioned to provide state-of-the-art global coverage of this increasingly important topic.

  • Each disease-oriented chapter is written to a highly structured template and provides key information on incidence, genetics, morphology, presentation, investigation and imaging, and treatment and intervention.

  • Congenital defects are illustrated with full-color line drawings and by the appropriate imaging modality (for example, EKG, x-ray, echocardiogram, MRI, CT, ).

  • Provides coverage of long-term outcomes, including the management of pregnant patients and patients undergoing non-cardiac surgery.
  • Features the addition of four new chapters: A Historic Perspective; Quality of Life in Patients with Pulmonary Hypertension; Psychosocial Issues in ACHD; Supportive and Palliative Care for End-Stage ACHD.

Table of Contents

Section Title Page Action Price
Front Cover Cover
Diagnosis and Management of Adult Congenital Heart Disease i
Copyright ii
Dedication iii
CONTRIBUTORS iv
FOREWORD xi
PREFACE xii
CONTENTS xiii
I - General Principles 1
1 - ADULTS WITH CONGENITAL HEART DISEASE: A GROWING POPULATION 2
Global Estimates of Incidence and Birth Prevalence of Congenital Heart Disease 2
Changes in Mortality, Survival, and Life Expectancy in the Congenital Heart Disease Population 2
Prevalence and Numbers of Adult Congenital Heart Disease 4
ORGANIZATION OF QUALITY-DRIVEN CARE 4
Targeting Disease Burden and Mortality 4
Impact of Specialized Adult Congenital Heart Disease Care 5
Manpower, Training, Education, and Research 7
Conclusions 8
REFERENCES 8
2 - Grown-Up Congenital Heart or Adult Congenital Heart Disease: Historical Perspectives 10
3 - Cardiac Morphology and Nomenclature 13
Sequential Segmental Analysis: General Philosophy 13
Morphology of the Cardiac Chambers 13
ATRIAL CHAMBERS 13
VENTRICLES 14
GREAT ARTERIES 16
Arrangement of Atrial Chambers 17
Determination of Ventricular Morphology and Topology 17
Analysis of the Atrioventricular Junction 18
Determination of Morphology of the Great Arteries 20
Analysis of the Ventriculoarterial Junction 20
Associated Malformations 21
Location of the Heart 21
Conclusion 22
REFERENCES 22
4 - Adults With Congenital Heart Disease: A Genetic Perspective 24
Genetic Basis of Congenital Heart Disease 24
Genetics in the Adult Congenital Heart Disease Population 24
Assessment by the Adult Congenital Heart Disease Clinician 25
ACCESS TO GENETICS EXPERTISE IN ADULT CONGENITAL HEART DISEASE CLINICS 26
Genetic Testing 26
TYPES OF TESTING 26
WHEN TO OFFER TESTING 28
PREPARING THE PATIENT FOR GENETIC TESTING 28
IMPLICATIONS OF GENETIC TEST RESULTS 28
IMPLICATIONS FOR FAMILY MEMBERS 29
Recurrence Risk of Congenital Heart Disease 29
REFERENCES 30
5 - Clinical Assessment 31
Medical History 31
ANATOMIC DIAGNOSIS 31
SURGICAL/INTERVENTIONAL TREATMENT 31
COMMON SEQUELA POST INTERVENTION 32
SYMPTOMATOLOGY 32
Physical Examination 32
PHYSICAL APPEARANCE 32
ARTERIAL PULSE 32
VEINS: JUGULAR AND PERIPHERAL 33
CHEST INSPECTION 33
PRECORDIAL PERCUSSION AND PALPATION 33
AUSCULTATION 33
Electrocardiogram 35
Chest Radiograph 37
Conclusion 40
REFERENCES 40
6 - Echocardiography 41
Sequential Segmental Analysis 41
Echocardiography in Specific Lesions 41
ATRIAL SEPTAL DEFECTS 41
Anatomy and Physiology 41
Associated Lesions 41
Transthoracic Echocardiography in Patients With Unrepaired Atrial Septal Defects 41
Contrast Echo 43
Transesophageal Echocardiography During the Surgical and Interventional Closure of Atrial Septal Defects 43
ATRIOVENTRICULAR SEPTAL DEFECT 43
Anatomy and Physiology 43
Associated Anomalies 44
Transthoracic Echocardiography in Unoperated Patients 44
Transesophageal Echocardiography 45
Three-Dimensional Transthoracic Echocardiography 45
Transthoracic Echocardiography in Operated Patients 45
VENTRICULAR SEPTAL DEFECTS 45
Anatomy and Physiology 45
Associated Lesions 46
Transthoracic Echocardiography in Unoperated Patients 47
CLOSURE OF VENTRICULAR SEPTAL DEFECTS 48
Transthoracic Echocardiography in Operated Patients 48
Three Dimensional Echocardiography 48
PATENT DUCTUS ARTERIOSUS 49
Anatomy and Physiology 49
Transthoracic Echocardiography in Unoperated Patients 49
Transthoracic Echocardiography in Operated Patients 50
Special Consideration 50
Three-Dimensional Echocardiography 50
COARCTATION OF THE AORTA 50
Anatomy and Physiology 50
Associated Lesions 50
Transthoracic Echocardiography in Unoperated Patients 50
Surgical Treatment 51
Interventional Treatment 51
Transthoracic Echocardiography After Repair 52
Three-Dimensional Echocardiography 52
PULMONARY STENOSIS 52
II - Septal Defects 305
29 - Atrial Septal Defect (Interatrial Communication) 306
Definition and Morphology 306
Genetics and Epidemiology 306
Early Presentation and Management 307
TRANSCATHETER CLOSURE 307
Late Outcome 308
SURVIVAL AND FUNCTIONAL STATUS 308
LATE COMPLICATIONS 308
Outpatient Assessment 309
OPERATED PATIENTS 309
UNOPERATED PATIENTS 309
History and Clinical Examination 309
Pulse Oximetry 310
Electrocardiography 310
Chest Radiography 310
Echocardiography 310
Cardiac Catheterization 310
Magnetic Resonance Imaging 311
Computed Tomographic Angiography 312
Exercise Oxygen Saturation 312
Open-Lung Biopsy 312
Additional Tests 312
Late Management Options 312
LATE INTERVENTION 312
SURGICAL OUTCOMES 313
DEVICE CLOSURE 313
LATE REINTERVENTION 313
Arrhythmia and Sudden Cardiac Death 313
Pregnancy 313
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 314
REFERENCES 314
30 - Ventricular Septal Defect 316
Definition and Morphology 316
Associated Abnormalities 316
Prevalence and Genetic Factors 316
Pathophysiology 316
Early Clinical Presentation 317
Management in Childhood 318
MEDICAL THERAPY AND THE SURGICAL CLOSURE OF VENTRICULAR SEPTAL DEFECTS 318
TRANSCATHETER CLOSURE 318
Late Outcome and Complications 319
UNOPERATED PATIENTS 319
OPERATED PATIENTS 319
Outpatient Assessment of the Adult Patient 320
PHYSICAL EXAMINATION 320
ELECTROCARDIOGRAPHY 322
CHEST X-RAY 322
ECHOCARDIOGRAPHY 322
CARDIAC MAGNETIC RESONANCE IMAGING 322
CARDIAC CATHETERIZATION 322
Management of the Adult Patient 323
PREGNANCY 323
PHYSICAL ACTIVITY 323
LEVEL OF SURVEILLANCE 324
INFECTIVE ENDOCARDITIS AND ENDOCARDITIS PROPHYLAXIS 324
REFERENCES 325
31 - Atrioventricular Septal Defects 326
Definition and Morphology 326
DEFINITIONS 326
MORPHOLOGY 326
International Pediatric and Congenital Cardiac Code Classification 326
Rastelli Classification 326
Atrioventricular Valves, Left Ventricle Outflow Tract Anatomy, and Other Anatomical Characteristics 327
ASSOCIATED INTRACARDIAC AND EXTRACARDIAC ANOMALIES OF ATRIOVENTRICULAR SEPTAL DEFECTS 328
Atrioventricular Conduction Tissue 329
Embryology, Epidemiology, and Genetics/Maternal Exposure 329
EMBRYOLOGY 329
EPIDEMIOLOGY 330
GENETICS AND MATERNAL EXPOSURE 331
Early Presentation 331
PRENATAL DIAGNOSIS 331
POSTNATAL DIAGNOSIS 332
Physical Exam 333
Electrocardiography 333
Chest X-Ray 333
3D Echo and Transesophageal Echo 334
Cardiac Computed Tomography 334
Cardiac Catheterization and Angiography 335
SURGICAL MANAGEMENT OF ATRIOVENTRICULAR SEPTAL DEFECTS 335
LATE OUTCOMES 336
Outpatient Assessment of the Adult with Atrioventricular Septal Defect 336
UNOPERATED PATIENTS 336
OPERATED PATIENTS 337
PREGNANCY MANAGEMENT 337
ENDOCARDITIS PROPHYLAXIS 337
REFERENCES 337
III - Diseases of the Mitral Valve 339
32 - Cor Triatriatum and Congenital Mitral Stenosis 340
Introduction 340
Cor Triatriatum 340
DEFINITION AND EPIDEMIOLOGY 340
EMBRYOLOGY AND ANATOMY 340
Anatomic Variations and Classification 340
NATURAL HISTORY AND PRESENTATION 340
Presentation in Childhood 340
Adult Presentation 341
SYNDROMES AND ASSOCIATED DEFECTS 341
DIAGNOSIS 341
Examination 341
Electrocardiogram 341
Chest X-Ray 341
Echocardiogram 341
Computed Tomography and Magnetic Resonance Imaging 343
Exercise Testing 343
Cardiac Catheterization 343
MANAGEMENT 343
SPECIAL SITUATIONS 343
Pregnancy 343
Endocarditis Prophylaxis and Exercise Recommendations 344
FOLLOW UP AND OUTCOME 344
Congenital Mitral Stenosis 344
DEFINITION AND EPIDEMIOLOGY 344
ANATOMY AND VARIATIONS 344
PRESENTATION 345
Presentation in Childhood 345
Adult Presentation 345
SYNDROMES AND ASSOCIATED DEFECTS 345
DIAGNOSIS 345
Electrocardiogram 345
Chest X-Ray 345
Echocardiogram 345
Computed Tomography and Magnetic Resonance Imaging 346
Cardiac Catheterization 346
MANAGEMENT 346
Presentation in Childhood 346
Adult Presentation 346
Outcome and Prognosis 346
SPECIAL SITUATIONS 346
Pregnancy 346
Endocarditis Prophylaxis, Follow-up, and Exercise 346
REFERENCES 346
33 - Mitral Valve Prolapse, Mitral Regurgitation 348
Anatomy of the Mitral Valve 348
Definition, Etiology, and Pathology of Mitral Valve Prolapse 348
Prevalence of Mitral Valve Prolapse 349
Early Presentation of Mitral Valve Prolapse 349
Management of Mitral Valve Prolapse 350
Late Outcome of Mitral Valve Prolapse 350
Late Management Options 351
Pregnancy 351
Exercise and Mitral Valve Prolapse 352
Conclusions 352
REFERENCES 352
34 - Partial Anomalous Pulmonary Venous Connections and the Scimitar Syndrome 354
Definition and Morphology 354
Scimitar Syndrome 355
Genetics and Epidemiology 355
Early Presentation and Management 355
Late Outcome 357
OPERATED PATIENTS 357
IV - Diseases of the Left Ventricular Outflow Tract 363
35 - Valvular Aortic Stenosis 364
Definition, Morphology, and Epidemiology 364
Associated Lesions 364
Genetics and Molecular Biology 364
Pathophysiology and Clinical Course (Without Intervention) 366
Physical Examination 366
Investigations 367
BRAIN NATRIURETIC PEPTIDE 367
ELECTROCARDIOGRAPHY 367
CHEST RADIOGRAPHY 367
ECHOCARDIOGRAPHY 367
COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING 368
CARDIAC CATHETERIZATION 369
STRESS TESTING 369
Management 370
MEDICAL MANAGEMENT 371
BALLOON AORTIC VALVULOPLASTY 371
SURGERY 372
Timing 372
Surgical Options 372
Transcatheter Aortic Valve Implantation 373
PREGNANCY 374
ENDOCARDITIS 375
EXERCISE 376
Aortic Root Dilation 376
Aortic Stenosis 376
Outcomes and Follow-Up 376
REFERENCES 377
36 - Subvalvular and Supravalvular Aortic Stenosis 379
Subvalvular Aortic Stenosis 379
DEFINITION AND MORPHOLOGY 379
ASSOCIATED LESIONS 379
GENETICS AND ETIOLOGY 379
EARLY PRESENTATION AND MANAGEMENT 379
OUTPATIENT ASSESSMENT 380
MANAGEMENT 380
LATE OUTCOMES AND COMPLICATIONS 381
LEVEL OF FOLLOW-UP 382
Supravalvular Aortic Stenosis 382
DEFINITION AND MORPHOLOGY 382
ASSOCIATED LESIONS 382
GENETICS AND ETIOLOGY 382
OUTPATIENT ASSESSMENT 383
LATE MANAGEMENT 383
LATE OUTCOMES 384
LEVEL OF FOLLOW-UP 385
Pregnancy in the Presence of Left Ventricular Outflow Tract Obstruction 385
REFERENCES 385
37 - Aortic Regurgitation 387
Etiology 387
Primary Aortic Valve Abnormality 387
Aortic Root Pathology 387
Aortic Regurgitation Associated With Other Congenital Lesions 387
Acquired Aortic Regurgitation 387
Clinical and Natural Course in Children with Aortic Regurgitation 387
Acute Aortic Regurgitation 388
Chronic Aortic Regurgitation 388
PATHOPHYSIOLOGY 388
CLINICAL PRESENTATION 388
History 388
Physical Examination 388
Chest Radiography 389
Echocardiography 389
Cardiac Catheterization 390
Magnetic Resonance Imaging 390
Exercise Testing 390
Stages of Chronic Aortic Regurgitation 390
Disease Progression Considerations 390
Outpatient Management 390
Vasodilator Therapy 390
Timing of Surgery 390
Surgical Options 392
Transcatheter Aortic Valve Replacement for Aortic Regurgitation 392
Outcomes After Surgery 393
Pregnancy 393
Endocarditis Prophylaxis 393
Exercise 393
REFERENCES 394
38 - Sinus of Valsalva Aneurysms 395
Introduction 395
Morphology 395
Associated Defects 395
Epidemiology 395
Investigations 396
ELECTROCARDIOGRAPHY AND CHEST RADIOGRAPHY 396
IMAGING 396
Presentation 396
UNRUPTURED SINUS OF VALSALVA 396
RUPTURED SINUS OF VALSALVA 397
Management 397
RUPTURED SINUS OF VALSALVA ANEURYSM 397
Reoperation 398
NONRUPTURED ANEURYSMS 398
Outpatient Assessment 398
Arrhythmia and Sudden Death 398
Pregnancy 398
Level of Follow-Up and Endocarditis Prophylaxis 398
REFERENCES 399
V - Diseases of the Aorta 401
39 - Patent Ductus Arteriosus and Aortopulmonary Window 402
Patent Ductus Arteriosus 402
Embryology 402
Incidence and Classification 402
Late Outcome 402
Outpatient Assessment 403
PATIENTS WITH REPAIRED PATENT DUCTUS ARTERIOSUS 403
PATIENT WITH UNREPAIRED OR RESIDUAL PATENT DUCTUS ARTERIOSUS 403
CLINICAL EXAMINATION 404
ELECTROCARDIOGRAPHY 404
CHEST RADIOGRAPHY 404
ECHOCARDIOGRAPHY 404
CARDIAC CATHETERIZATION 404
COMPUTED TOPOGRAPHY AND CARDIAC MAGNETIC RESONANCE 404
Late Management Options 404
INDICATIONS FOR CLOSURE 404
CATHETER INTERVENTION (DEVICE CLOSURE) 405
SURGICAL CLOSURE 405
Pregnancy 405
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 406
Aortopulmonary Window 406
Definition and Morphology 406
Associated Lesions 406
Early Presentation 407
Late Presentation 407
Outpatient Assessment and Management 408
REFERENCES 408
40 - Aortic Coarctation and Interrupted Aortic Arch 409
Coarctation of the Aorta 409
DEFINITION AND MORPHOLOGY 409
GENETICS AND EPIDEMIOLOGY 409
EARLY PRESENTATION 409
MANAGEMENT 410
Surgical Treatment 410
Interventional Treatment 410
LATE OUTCOME 410
Survival and Functional Status 410
Late Complications 411
Arterial Hypertension 411
Re-coarctation or Residual Coarctation 412
Aneurysms of the Ascending Aorta or in the Region of the Aortic Isthmus 412
Infective Endocarditis or Endarteritis 413
Bicuspid Aortic Valve 413
Aneurysms of the Circle of Willis 413
Coronary Artery Disease 414
Elevation of the Left Shoulder 414
OUTPATIENT ASSESSMENT 414
Physical Findings 414
Electrocardiography 414
Chest Radiography 414
Echocardiography 415
Magnetic Resonance Imaging and Computed Tomography 415
Cardiac Catheterization 416
LATE MANAGEMENT OPTIONS 416
Medical Intervention 416
Surgical or Catheter Interventional Treatment 416
PREGNANCY 417
LEVEL OF FOLLOW-UP, ENDOCARDITIS PROPHYLAXIS, AND EXERCISE 417
Interrupted Aortic Arch 417
DEFINITION AND MORPHOLOGY 417
GENETICS AND EPIDEMIOLOGY 417
EARLY PRESENTATION 417
MANAGEMENT 418
Medical Treatment 418
Surgical Treatment 418
Transcatheter Treatment 418
LATE OUTCOME 418
Survival and Functional Status 418
Late Complications 418
OUTPATIENT ASSESSMENT 418
Physical Findings 418
Electrocardiography 418
Chest Radiography 418
Echocardiography 418
Magnetic Resonance Imaging and Computed Tomography 419
Cardiac Catheterization 419
LATE MANAGEMENT OPTIONS 419
LEVEL OF FOLLOW-UP, ENDOCARDITIS PROPHYLAXIS, AND EXERCISE 419
REFERENCES 419
41 - Truncus Arteriosus 421
Definition and Morphology 421
TRUNCAL VALVE 421
VENTRICULAR SEPTAL DEFECT 421
PULMONARY ARTERIES 421
CORONARY ARTERIES 421
DUCTUS ARTERIOSUS 422
VENTRICLES 423
ASSOCIATED ANOMALIES 423
Epidemiology and Genetics 423
Early Presentation and Natural History 423
Surgical Repair 423
Late Outcome and Management 423
OUTPATIENT ASSESSMENT 425
LATE REINTERVENTIONS 425
ARRHYTHMIAS 426
MEDICATION 426
PREGNANCY AND CONTRACEPTION 426
EXERCISE AND SPORTS PARTICIPATION 427
ENDOCARDITIS PROPHYLAXIS 427
REFERENCES 427
42 - Vascular Rings, Pulmonary Slings, and Other Vascular Abnormalities 429
Normal Embryogenesis 429
Classification and Morphology of Individual Lesions 429
NATIVE ANATOMIC ANOMALIES 429
Right Aortic Arch with Aberrant Left Subclavian Artery 430
Right Aortic Arch with Mirror Image Branching 430
Left Aortic Arch With Aberrant Right Subclavian Artery 430
Left Aortic Arch with Retroesophageal Right Descending Aorta 431
Aberrant Left Brachiocephalic (Innominate) Artery 431
Cervical Arch 431
Absent Pulmonary Valve Syndrome 433
Direct Aortic Compression 433
Innominate Artery Compression 433
ACQUIRED UPPER AIRWAY COMPRESSION 433
Postoperative Airway Compression 433
Compression by the Left Atrium 433
Aortic Aneurysm 433
Genetics and Epidemiology 433
Clinical Manifestations 434
HISTORY 434
EXAMINATION 434
Investigations 435
CHEST RADIOGRAPHY, BRONCHOSCOPY, BRONCHOGRAPHY, AND LUNG FUNCTION TESTING 435
BARIUM SWALLOW 435
ECHOCARDIOGRAPHY 435
CARDIAC CATHETERIZATION (RADIOGRAPHIC ANGIOGRAPHY) 435
MAGNETIC RESONANCE IMAGING AND COMPUTED TOMOGRAPHY 436
Management 436
RELIEF OF NATIVE ANATOMIC ANOMALIES 436
RELIEF OF ACQUIRED UPPER AIRWAY OBSTRUCTION 437
Late Outcome 438
Arrhythmia and Sudden Cardiac Death 438
Pregnancy 438
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 438
REFERENCES 438
VI - Diseases of theTricuspid Valve 441
43 - Ebstein Anomaly 442
Definition and Morphology 442
ANATOMIC FEATURES 442
Genetics and Epidemiology 442
Early Presentation 442
Outpatient Assessment 442
IMAGING 443
ELECTROPHYSIOLOGY 443
EXERCISE TESTING 443
ADDITIONAL EVALUATIONS 444
Early Management 444
Late Outcome 444
NATURAL HISTORY 444
Late Management 444
ELECTROPHYSIOLOGY 444
OPERATIVE INTERVENTION 444
TRICUSPID VALVE REPAIR 444
TRICUSPID VALVE REPLACEMENT 447
VENTRICLE REPAIR 447
INTRAOPERATIVE ARRHYTHMIA PROCEDURES 447
EARLY OPERATIVE OUTCOMES AND CARE 447
LATE OPERATIVE OUTCOMES 448
CARDIAC TRANSPLANTATION 448
Pregnancy 448
Level of Follow-up, Endocarditis Prophylaxis, Exercise 448
REFERENCES 448
44 - Tricuspid Regurgitation and Stenosis 450
Definitions and Morphology 450
TRICUSPID STENOSIS 450
TRICUSPID REGURGITATION 450
Genetics and Epidemiology 451
Early Presentation and Management 451
Late Outcome 452
SURVIVAL AND FUNCTIONAL STATUS 452
Outpatient Assessment 452
UNOPERATED PATIENTS 452
Role of Echocardiography 453
OPERATED PATIENTS 454
Late Management Options 455
LATE INTERVENTION 455
LATE REINTERVENTION 456
Arrhythmia and Sudden Cardiac Death 456
Pregnancy, Exercise, and Endocarditis Prophylaxis 457
REFERENCES 457
VII - Diseases of the Right Ventricular Outflow Tract 459
45 - Pulmonary Stenosis 460
Definition and Morphology 460
Early Presentation and Management 460
Late Outcome 460
SURVIVAL AND FUNCTIONAL STATUS 460
Late Complications 460
Outpatient Assessment 461
UNREPAIRED ADULT 461
Physical Examination 461
Electrocardiography 461
Chest Radiography 461
Echocardiography 461
Stress Test 462
Magnetic Resonance Imaging or Computed Tomography 462
Cardiac Catheterization 462
OPERATED/REPAIRED ADULT 463
Late Management Options 463
INDICATIONS FOR INTERVENTION AND REINTERVENTION 463
Arrhythmia and Sudden Cardiac Death 463
Pregnancy 463
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 464
REFERENCES 464
46 - Double-Chambered Right Ventricle 465
Definition and Morphology 465
Genetics and Epidemiology 465
Presentation and Diagnosis 466
Management 467
Late Outcomes 469
SURVIVAL AND FUNCTIONAL STATUS 469
Outpatient Assessment of the Adult With Double-Chambered Right Ventricle 469
REPAIRED PATIENTS 469
UNREPAIRED PATIENTS 469
ARRHYTHMIA AND SUDDEN CARDIAC DEATH 469
PREGNANCY 470
LEVEL OF FOLLOW-UP 470
ENDOCARDITIS PROPHYLAXIS 470
EXERCISE 470
REFERENCES 470
VIII - Cyanotic Conditions 473
47 - Tetralogy of Fallot 474
Definition and Morphology 474
VENTRICULAR SEPTAL DEFECT 474
PULMONARY STENOSIS 474
AORTIC OVERRIDING 474
ASSOCIATED LESIONS 474
Genetics and Epidemiology 475
Early Presentation and Management 475
Late Outcomes 476
SURVIVAL AND FUNCTIONAL STATUS 476
Repaired Patients 476
Palliated Patients 476
Unoperated Patients 477
Outpatient Assessment 477
REPAIRED PATIENTS 477
PALLIATED-ONLY OR UNOPERATED PATIENTS 479
Late Management Options 480
REPAIRED PATIENTS 480
Indications for Reintervention 480
Surgical/Catheter Interventional Options 481
PALLIATED-ONLY OR UNOPERATED PATIENTS 484
Arrhythmia and Sudden Cardiac Death 484
CONDUCTION ABNORMALITIES 484
SUPRAVENTRICULAR ARRHYTHMIA 484
VENTRICULAR ARRHYTHMIA 484
Nonsustained Ventricular Arrhythmia 484
Sustained Monomorphic Ventricular Tachycardia 484
SUDDEN CARDIAC DEATH AND RISK STRATIFICATION 485
Pregnancy 486
Level of Follow-Up 487
Endocarditis Prophylaxis 487
Exercise 487
Future Therapies 487
REFERENCES 487
48 - Pulmonary Atresia With Ventricular Septal Defect 489
General Overview 489
Anatomy 489
PULMONARY VASCULATURE 489
INTRACARDIAC ANATOMY 489
Genetics and Epidemiology 491
Early Presentation 491
Management 492
Long-Term Outcome 493
Outpatient Assessment 493
Imaging 494
Long-Term Management 495
INTERVENTION 495
Pregnancy 496
Other Recommendations 497
REFERENCES 497
49 - Absent Pulmonary Valve Syndrome 499
Definition and Morphology 499
Epidemiology and Genetics 499
Tetralogy of Fallot with Absent Pulmonary Valve 499
CLINICAL PRESENTATION AND DIAGNOSIS 499
MANAGEMENT AND OUTCOME 500
LONG-TERM FOLLOW-UP 500
Absent Pulmonary Valve in Isolation 501
CLINICAL PRESENTATION AND DIAGNOSIS 501
MANAGEMENT AND OUTCOME 501
Summary 501
REFERENCES 502
50 - Pulmonary Atresia With Intact Ventricular Septum 503
Definition and Morphology 503
Genetics and Epidemiology 503
Fetal Presentation 503
Early Presentation and Management 505
BIVENTRICULAR STRATEGY 505
1.5-VENTRICLE REPAIR 505
UNIVENTRICULAR STRATEGY 506
SEVERELY DILATED RIGHT VENTRICLES 506
Late Outcome 506
SURVIVAL AND FUNCTIONAL STATUS 506
Biventricular Repair 507
1.5-Ventricle Repair 507
Univentricular Repair 507
Outpatient Assessment 508
Late Management Options 509
SEPARATED PULMONARY AND SYSTEMIC CIRCULATIONS ACHIEVED 509
Biventricular Repair 509
1.5-Ventricle Repair 510
Univentricular Repair 510
INCOMPLETE SEPARATION OF PULMONARY AND SYSTEMIC CIRCULATIONS 510
Good-Sized Right Ventricle 510
Medium-Sized Right Ventricle 510
Small-Sized Right Ventricle 511
Arrhythmia and Sudden Cardiac Death 511
Pregnancy 511
BIVENTRICULAR REPAIR WITH RESIDUAL PULMONARY STENOSIS OR REGURGITATION 511
UNIVENTRICULAR CIRCULATION 511
MIXED CIRCULATIONS WITH CYANOSIS 511
Follow-Up, Endocarditis Prophylaxis, and Exercise 511
REFERENCES 512
51 - Transposition of the Great Arteries 513
Definition and Morphology 513
GREAT ARTERY ORIGINS 513
CORONARY ARTERIES 513
ASSOCIATED DEFECTS 513
Ventricular Septal Defect 513
Left Ventricular Outflow Tract Obstruction 513
Genetics and Epidemiology 514
Early Presentation and Management 514
BALLOON ATRIAL SEPTOSTOMY 514
ATRIAL BAFFLE REPAIR 515
Mustard and Senning Operations 515
Arterial Switch Operation 515
Rastelli Operation 516
Late Outcome 516
NATURAL HISTORY 516
ATRIAL BAFFLE REPAIRS 516
Survival and Functional Status 516
Arrhythmias and Sudden Cardiac Death 517
Bradyarrhythmias 517
Tachyarrhythmias 518
Sudden Death 518
Ventricular Function 519
Tricuspid Valve Function 519
Baffle Obstruction and Baffle Leaks 520
Pulmonary Hypertension 520
ARTERIAL SWITCH OPERATION 520
Survival and Functional Status 520
Arrhythmias and Sudden Cardiac Death 520
Ventricular Function 520
Pulmonary Artery Stenosis 520
Neoaortic Valve Regurgitation 520
Coronary Arterial and Vascular Complications 521
Neurologic Outcomes 521
RASTELLI OPERATION 521
Survival and Functional Status 521
Arrhythmias and Sudden Cardiac Death 521
Ventricular Function 521
Conduit Stenosis and Outflow Tract Obstruction 521
Outpatient Assessment 521
ATRIAL BAFFLE AND RASTELLI PATIENTS 521
ARTERIAL SWITCH PATIENTS 522
Late Management Options 523
MEDICAL THERAPY 523
SURGICAL AND CATHETER INTERVENTIONS 523
Arterial Switch Conversion 523
Pulmonary Artery Banding 524
Radiofrequency Ablation of Arrhythmias 524
Implantable Cardiac Defibrillators 524
Resynchronization Therapy 524
Coronary Artery Interventions 524
IX - Univentricular Hearts 563
55 - Double-Inlet Ventricle 564
Definition and Morphology 564
CONDUCTION SYSTEM 564
ASSOCIATED LESIONS 564
Genetics and Epidemiology 565
Early Presentation and Management 565
Management 566
Late Outcome 566
Outpatient Assessment 567
OPERATED PATIENTS 567
UNOPERATED OR PALLIATED PATIENTS (WITH NON-FONTAN PROCEDURES) 567
Late Management Options 567
LATE INTERVENTION 567
LATE REINTERVENTION 567
Arrhythmia and Sudden Cardiac Death 567
Pregnancy 568
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 568
REFERENCES 568
56 - Atrioventricular Valve Atresia 570
Tricuspid Atresia 570
GENETICS AND EPIDEMIOLOGY 570
EARLY PRESENTATION AND MANAGEMENT 570
Unoperated Survival 570
Mitral Atresia and Hypoplastic Left Heart Syndrome 571
GENETICS AND EPIDEMIOLOGY 571
MORPHOLOGY 571
EARLY PRESENTATION 571
STAGED SURGICAL MANAGEMENT 572
Late Outcome 573
PROTEIN-LOSING ENTEROPATHY 573
ATRIAL ARRHYTHMIA 574
Outpatient Assessment 575
UNOPERATED OR POST-SHUNT PATIENTS WITH TRICUSPID ATRESIA 575
Post-Fontan or Post–Total Cavopulmonary Connection Patients With Tricuspid Atresia or Hypoplastic Left Heart Syndrome 575
Late Management Options 576
LATE INTERVENTION IN UNOPERATED OR SHUNT-PALLIATED PATIENTS WITH TRICUSPID ATRESIA 576
LATE REINTERVENTION IN PATIENTS AFTER A FONTAN PROCEDURE 576
Pregnancy and Contraception 577
CONTRACEPTION 577
PREGNANCY IN UNOPERATED OR SHUNT-PALLIATED PATIENTS 577
PREGNANCY IN POST–FONTAN PATIENTS 577
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 577
REFERENCES 577
57 - Heterotaxy and Isomerism of the Atrial Appendages 579
Definitions 579
Morphology 579
ATRIUM 579
BRONCHOPULMONARY ANATOMY 579
SPLEEN 580
ATRIOVENTRICULAR JUNCTIONS 580
VENTRICULOARTERIAL JUNCTIONS 581
VENOATRIAL CONNECTIONS 581
Epidemiology and Genetics 581
Associated Cardiac Lesions in Heterotaxy Syndrome 581
NONCARDIAC MALFORMATIONS 581
Early Presentation and Initial Management 582
INITIAL MANAGEMENT 582
Late Presentation and Outcomes 582
Complications and Late Management Options 582
Outpatient Assessment 582
ELECTROCARDIOGRAPHY 582
CHEST RADIOGRAPHY 583
ECHOCARDIOGRAPHY 583
MAGNETIC RESONANCE IMAGING AND COMPUTED TOMOGRAPHY 583
CARDIAC CATHETERIZATION 584
Conduction System Abnormalities and Arrhythmias 584
Pregnancy 584
Level of Follow-Up and Endocarditis Prophylaxis 584
REFERENCES 584
X - Coronary Artery Abnormalities 587
58 - Congenital Anomalies of the Coronary Arteries 588
Primary Congenital Coronary Anomalies 588
CLASSIFICATION 588
PREVALENCE 588
ECTOPIC CORONARY ARTERIES 589
Definition 589
Circumflex Artery Arising From the Right Sinus of Valsalva or Proximal Right Coronary Artery 589
Origin of Coronary Arteries in the Opposite Sinus 589
Right Coronary Artery Arising From the Left Sinus of Valsalva 590
Clinical Manifestations of Coronary Arteries Arising From the Opposite Sinus 590
Anatomic Diagnosis of a Coronary Artery Originating in the Opposite Sinus 591
Management 591
Anomalous Origin of the Left Coronary Artery in the Pulmonary Artery 594
Diagnosis 594
Management 594
CORONARY ARTERIOVENOUS SHUNTS 595
Anatomy and Physiology 595
Diagnosis 595
Management 595
Secondary Congenital Coronary Anomalies 595
TETRALOGY OF FALLOT 596
TRANSPOSITION OF THE GREAT ARTERIES 596
BICUSPID AORTIC VALVE 596
TRUNCUS ARTERIOSUS 596
PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM 596
REFERENCES 596
59 - Kawasaki Disease 598
Definition/Morphology 598
Genetics, Epidemiology and Etiology 598
Early Presentation and Management 598
Adult Onset Kawasaki Disease 599
Late Outcome, Long-Term Management 599
Patients With No Evidence of Coronary Artery Abnormalities 599
PATIENTS WITH TRANSIENT OR SMALL (<5 MM DIAMETER) OR MEDIUM (5 TO 8 MM) CORONARY ARTERY ANEURYSM 600
Patients With Large and Giant (>8 mm) Coronary Artery Aneurysm or Post Coronary Artery Occlusion 600
Myocardial Infarction 600
Coronary Artery Sequelae 601
Outpatient Assessment of the Adult With Kawasaki Disease 601
Late Management Opinions 602
Pregnancy 602
Level of Follow-Up 602
REFERENCES 603
XI - Other Lesions 605
60 - Myocarditis and Dilated Cardiomyopathy 606
Definition 606
Epidemiology and Etiology 606
Genetics of Dilated Cardiomyopathy 607
Pathogenesis 608
Clinical Presentation and Assessment 608
Evidence of Myocardial Inflammation and Infection 608
Management 609
Outpatient Assessment, Level of Follow-Up, and Exercise 609
Arrhythmia and Sudden Cardiac Death 610
Emerging Role of Cardiovascular Magnetic Resonance 610
Prognosis 610
Pregnancy 611
Conclusion 613
61 - Hypertrophic Cardiomyopathy 615
Definition 615
Morphology and Pathophysiology 615
DIASTOLIC FUNCTION 615
SYSTOLIC DYSFUNCTION 615
LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION 615
ARRHYTHMIA 615
Epidemiology 616
Genetics 616
Presentation and Outpatient Assessment 616
PHYSICAL EXAMINATION 616
ELECTROCARDIOGRAPHY 616
AMBULATORY ELECTROCARDIOGRAPHY 617
ECHOCARDIOGRAPHY 617
CARDIOPULMONARY EXERCISE TESTING 618
CARDIOVASCULAR MAGNETIC RESONANCE IMAGING 618
Late Outcomes 618
Management 618
FAMILY SCREENING 618
MANAGEMENT OF SYMPTOMS IN PATIENTS WITH LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION 619
MANAGEMENT OF SYMPTOMS WITHOUT LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION 619
Atrial Fibrillation 619
SUDDEN CARDIAC DEATH 620
Prevention of Sudden Cardiac Death 620
Pregnancy 620
Endocarditis Prophylaxis and Exercise 620
REFERENCES 621
62 - Constrictive Pericarditis and Restrictive Cardiomyopathy 622
Definition and Morphology 622
Epidemiology and Genetics 622
Early Presentation and Management 622
DIAGNOSIS 623
Pathophysiology 623
Past Medical History 623
Physical Examination 623
Biomarkers 624
Electrocardiography 624
Chest Radiography 624
Two-Dimensional and Doppler Echocardiography 624
Myocardial Properties 625
Effect of Respiration on Ventricular Filling 625
Computed Tomography and Magnetic Resonance Imaging 626
Cardiac Catheterization 627
Endomyocardial Biopsy 628
Exploratory Thoracotomy 629
TREATMENT 629
Late Outcome 629
Outpatient Assessment 629
Late Management Options 629
Arrhythmia and Sudden Cardiac Death 629
Pregnancy 630
Level of Follow-Up, Endocarditis Prophylaxis, and Exercise 630
REFERENCES 630
63 - Arrhythmogenic Cardiomyopathy 631
Pathologic Findings 631
Pathogenesis of Arrhythmogenic Cardiomyopathy 631
ABNORMAL CELL-CELL ADHESION 631
ABNORMAL INTERCELLULAR JUNCTION PROTEINS AND INTRACELLULAR SIGNALING 631
GAP JUNCTION AND ION CHANNEL REMODELING 632
FROM EXPERIMENTAL MODELS TO TARGET THERAPY 632
Clinical Findings and Natural History 632
ARRHYTHMOGENIC CARDIOMYOPATHY DIAGNOSIS 632
ARRHYTHMOGENIC CARDIOMYOPATHY DIAGNOSIS IN THE PEDIATRIC AGE 632
LEFT-DOMINANT ARRHYTHMOGENIC CARDIOMYOPATHY DIAGNOSIS 634
DIFFERENTIAL DIAGNOSIS 634
ARRHYTHMOGENIC CARDIOMYOPATHY GENES/MUTATIONS AND DIAGNOSTIC IMPLICATIONS 635
Outpatient Assessment, Management, and Treatment 636
CARDIAC TRANSPLANTATION 637
Risk Stratification 637
PREGNANCY 637
ENDOCARDITIS PROPHYLAXIS 637
ACKNOWLEDGMENTS 638
REFERENCES 638
64 - Noncompacted Myocardium 640
Definitions 640
Epidemiology 640
Pathology and Pathogenesis 640
Current Diagnostic Criteria 641
Clinical Presentation (Cardiac and Noncardiac Findings) 643
Association With Neuromuscular Disorders, Metabolic and Genetic Syndromes, and Congenital Heart Defects 644
Genetics 644
Management and Conclusion 646
REFERENCES 646
65 - Rheumatic Fever 649
Pathogenesis 649
EPIDEMIOLOGY 649
CLINICAL PICTURE 649
Special Clinical Manifestations 650
CARDITIS 650
MITRAL REGURGITATION—JET CHARACTERISTICS 650
MITRAL STENOSIS—JET CHARACTERISTICS 650
ARTHRITIS 651
CHOREA 651
ERYTHEMA MARGINATUM 651
SUBCUTANEOUS NODULES 651
Pathology 651
Natural History 651
Therapy of Inflammatory Manifestations 652
Conclusion 653
REFERENCES 653
66 - Cardiac Tumors 655
Diagnosis of Cardiac Tumors 655
GENERAL CLINICAL FEATURES 655
DIAGNOSTIC APPROACH 655
Treatment and Prognosis 656
Primary Benign Cardiac Tumors 656
MYXOMA 656
Clinical Manifestations 657
Diagnosis 657
Management and Treatment 657
PAPILLARY FIBROELASTOMA 658
CLINICAL MANIFESTATIONS 658
SELECTED TERMS USED IN ADULT CONGENITAL HEART DISEASE 678
Acknowledgments 701
INDEX 703
A 703
B 705
C 705
D 708
E 709
F 710
G 711
H 711
I 712
J 713
K 713
L 713
M 714
N 714
O 715
P 715
Q 717
R 717
S 718
T 719
U 720
V 720
W 721
Z 721